Back to Search Start Over

LXA4 protects against hypoxic-ischemic damage in neonatal rats by reducing the inflammatory response via the IκB/NF-κB pathway.

Authors :
Zhu, Jin-jin
Yu, Bin-yuan
Fu, Chang-chang
He, Min-zhi
Zhu, Jiang-hu
Chen, Bin-wen
Zheng, Yi-hui
Chen, Shang-qin
Fu, Xiao-qin
Li, Pei-jun
Lin, Zhen-lang
Source :
International Immunopharmacology. Dec2020:Part B, Vol. 89, pN.PAG-N.PAG. 1p.
Publication Year :
2020

Abstract

• LXA4 against HI brain damage by protecting the integrity of blood–brain barrier. • LXA4 reduces neuronal apoptosis following HI brain damage in neonatal rats. • LXA4 exerts a neuroprotective effect via the IκB/NF-κB pathway in neonatal rats. Hypoxia and the resultant decreases in cerebral blood flow in the perinatal period can lead to neonatal hypoxic-ischemic (HI) brain injury, which can, in turn, cause severe disability or even death. However, the efficacy of current treatment strategies remains limited. Several studies have demonstrated that lipoxin A4 (LXA4), as one of the earliest types of endogenous lipid mediators, can inhibit the accumulation of neutrophils, arrest inflammation, and promote the resolution of inflammation. However, research on LXA4 in the nervous system has rarely been carried out. In the present study, we sought to investigate the protective effect of LXA4 on HI brain damage in neonatal rats, as well as the underlying mechanisms. Through experiments conducted using an HI animal model, we found that the LXA4 intervention promoted the recovery of neuronal function and tissue structure following brain injury while maintaining the integrity of the blood–brain barrier in addition to reducing cerebral edema, infarct volume, and inflammatory responses. Our results suggest that LXA4 interfered with neuronal oxygen-glucose deprivation insults, reduced the expression of inflammatory factors, inhibited apoptosis, and promoted neuronal survival in vitro. Finally, the LXA4 intervention attenuated HI-induced activation of inhibitor kappa B (IκB) and degradation of nuclear factor-κB (NF-κB). In conclusion, our data suggest that LXA4 exerts a neuroprotective effect against neonatal HI brain damage through the IκB/NF-κB pathway. Our findings will help inform future studies regarding the effects of LXA4 on neuroinflammation, blood–brain barrier integrity, and neuronal apoptosis. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15675769
Volume :
89
Database :
Academic Search Index
Journal :
International Immunopharmacology
Publication Type :
Academic Journal
Accession number :
147382594
Full Text :
https://doi.org/10.1016/j.intimp.2020.107095